Appointment booking for Dr. Petronilo Costa, MD is currently not available.Dr. Petronilo Costa, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Petronilo Costa, MD (he/him) is a Pediatrician in Deerfield, IL with over 17 years of experience. What is your opinion of Dr. Petronilo Costa, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Petronilo Costa, MD has received over $840 which includes payments from the following companies:
$163.58 from Neurocrine Biosciences, Inc.
$150.74 from Alkermes, Inc.
$113.28 from Shire North American Group Inc
$74.52 from Lundbeck LLC
$54.78 from OWP Pharmaceuticals, Inc.
$53.07 from Avanir Pharmaceuticals, Inc.
$52.03 from Teva Pharmaceuticals USA, Inc.
$42.19 from Otsuka America Pharmaceutical, Inc.
$20.91 from Arbor Pharmaceuticals, Inc.
$19.34 from Sage Therapeutics, Inc.
$18.96 from Adlon Therapeutics L.P.
$18.25 from Takeda Pharmaceuticals U.S.A., Inc.
$16.76 from LILLY USA, LLC
$13.52 from Sentynl Therapeutics, Inc.
$13.30 from Currax Pharmaceuticals LLC
$11.30 from Takeda Pharmaceuticals America, Inc.
$3.71 from Sunovion Pharmaceuticals Inc.
Payments received by Dr. Petronilo Costa, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!